Polaris Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $24.2M | Sell |
|
|||||
|
2019
Q1 | $160M | Sell |
|
|||||
|
2018
Q4 | $159M | Buy |
|
|||||
|
2018
Q3 | $213M | Buy |
|
|||||
|
2018
Q2 | $221M | Sell |
|
|||||
|
2018
Q1 | $168M | Buy |
|
|||||
|
2017
Q4 | $169M | Buy |
|
|||||
|
2017
Q3 | $70.2M | Buy |
|
|||||
|
2017
Q2 | $114M | Buy |
|
|||||
|
2017
Q1 | $67.4M | Buy |
|
|||||
|
2016
Q4 | $71.2M | Buy |
|
|||||
|
2016
Q3 | $82.5M | Sell |
|
|||||
|
2016
Q2 | $91.8M | Buy |
|
|||||
|
2016
Q1 | $96.6M | Sell |
|
|||||
|
2015
Q4 | $118M | Buy |
|
|||||
|
2015
Q3 | $96.6M | Buy |
|
|||||
|
2015
Q2 | $99.3M | Buy |
|
|||||
|
2015
Q1 | $103M | Sell |
|
|||||
|
2014
Q4 | $102M | Buy |
|